Mather Group’s iShares US Medical Devices ETF IHI Stock Holding History

Mather Group’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.9K	Hold	646	–	–	﹤0.01%	1221
2026 Q1	$34.5K	Buy	+646	New	+$37.9K	﹤0.01%	1142
2025 Q4	–	Sell	-646	Closed	-$38.8K	–	1116
2025 Q3	$38.8K	Buy	+646	New	+$39.5K	﹤0.01%	963
2025 Q2	–	Sell	-646	Closed	-$38.9K	–	1133
2025 Q1	$38.9K	Hold	646	–	–	﹤0.01%	942
2024 Q4	$37.7K	Hold	646	–	–	﹤0.01%	925
2024 Q3	$38.3K	Sell	646 -450	-41%	-$25.7K	﹤0.01%	930
2024 Q2	$64.2K	Buy	1,096 +378	+53%	+$21.2K	﹤0.01%	928
2024 Q1	$38.8K	Buy	+718	New	+$40.6K	﹤0.01%	925

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Mather Group's IHI Position: Q2 2026 in Review

Mather Group held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 646 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1221.

Mather Group first reported a position in IHI in Q1 2024 and has held it in 8 quarters since. The position peaked at $64.2K in Q2 2024. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Mather Group held 646 shares of iShares US Medical Devices ETF worth $31.9K as of Q2 2026.
Mather Group left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
iShares US Medical Devices ETF made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1221 holding.
Mather Group first reported a position in iShares US Medical Devices ETF in Q1 2024 and has held it in 8 quarters since.
Mather Group's iShares US Medical Devices ETF position peaked at $64.2K in Q2 2024.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.